Dergiler / Journal of Basic and Clinical Health Sciences / 2021 / Cilt: 5 - Sayı: 2

DEMONSTRATION OF MUTATION DEVELOPMENT AND VIRULENCE CHANGE IN REFERENCE CANDIDA STRAINS EXPOSED TO CASPOFUNGIN

Sayfa
115–123
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

No significant difference was found in virulence properties of reference strains andcaspofungin exposed strains.Conclusions: In conclusion, it was understood that the fact that sensitive strains were exposed tocaspofungin even at low concentrations caused an increase in MIC, and that virulence and drugresistance should be evaluated independently.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Purpose: Echinocandin resistance is causing problems in the treatment.
📊
Temel Bulgular & Veri:The aim of thisstudy was to compare the resistance of reference Candida strains exposed to caspofungin and toinvestigate whether there was a difference in virulence factors between exposed and non-exposed withcaspofungin.Methods: Caspofungin susceptible reference strains, exposed to caspofungin during their incubation incaspofungin containing agar plates at concentrations of 16-0.03 µg/ml.
💡
Sonuç & Katkı:No significant difference was found in virulence properties of reference strains andcaspofungin exposed strains.Conclusions: In conclusion, it was understood that the fact that sensitive strains were exposed tocaspofungin even at low concentrations caused an increase in MIC, and that virulence and drugresistance should be evaluated independently.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Purpose: Echinocandin resistance is causing problems in the treatment. FKS gene mutations weredetected on the genomes of the resistant Candida strains exposed to echinocandins. The aim of thisstudy was to compare the resistance of reference Candida strains exposed to caspofungin and toinvestigate whether there was a difference in virulence factors between exposed and non-exposed withcaspofungin.Methods: Caspofungin susceptible reference strains, exposed to caspofungin during their incubation incaspofungin containing agar plates at concentrations of 16-0.03 µg/ml. MIC values of caspofungin weredetermined all strains. FKS gene regions of the caspofungin exposed strains were sequenced in order toreveal the difference between the reference strains. Relationship between caspofungin exposure andvirulence properties were investigated in vivo and in vitro methodologies. The in vivo virulence study onthe mini-experimental animal model Galleria mellonella (wax moth) was performed.Results: MIC values of the caspofungin exposed strains were found to be increased as one/two folddilution when compared to the sensitive reference strains. The result of FKS gene sequence no mutationis detected in the reference strains, while a point mutation in caspofungin exposed C. glabrata strainswere detected. No significant difference was found in virulence properties of reference strains andcaspofungin exposed strains.Conclusions: In conclusion, it was understood that the fact that sensitive strains were exposed tocaspofungin even at low concentrations caused an increase in MIC, and that virulence and drugresistance should be evaluated independently.

🔖

Bu Makaleye Atıf Yap

BALTACI, N., KALKANCI, A. (2022). DEMONSTRATION OF MUTATION DEVELOPMENT AND VIRULENCE CHANGE IN REFERENCE CANDIDA STRAINS EXPOSED TO CASPOFUNGIN. Journal of Basic and Clinical Health Sciences, Cilt: 5 - Sayı: 2, 115–123. https://ajindex.com/articles/560476

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Touil HF., Boucherit K, Boucherit-Otmani Z et al. Optimum Inhibition of Amphotericin-B-Resistant Candida albicans Strain in Single-and MixedSpecies Biofilms by Candida and Non-Candida Terpenoids. Biomolecules. 2020;10:342
  2. Perlin DS. Mechanisms of echinocandin antifungal drug resistance. Ann New York Acad Sci 2015;1354:1-11
  3. Beyer R, Spettel K, Zeller I et al. Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria. Mycoses. 2019;62:357-367
  4. Pfaller MA, Diekema DJ, Turnidge JD et al. Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016. Open Forum Infect Dis 2019;6 Suppl 1:79-94
  5. Toutounji M, Tokajian S, Khalaf RA. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin. Fungal Genet Biol 2019;127:12-22
  6. Bordallo-Cardona MÁ, Escribano P, de la Pedrosa EGG et al. In vitro exposure to increasing micafungin concentrations easily promotes echinocandin resistance in Candida glabrata isolates. Antimicrob Agents Ch. 2017; 61: e01542-16
  7. Chassot F, Venturini TP, Piasentin FB et al. Exploring the in vitro resistance of Candida parapsilosis to echinocandins. Mycopathologia. 2016;181:663-70
  8. Shields RK, Kline EG, Healey KR, et al. Spontaneous mutational frequency and FKS mutation rates vary by echinocandin agent against Candida glabrata. Antimicrob Agents Ch. 2019;63:e01692-18
  9. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts- Third Edition: M27–A3. NCCLS, Wayne, PA.2008
  10. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts, Third Edition informational supplement M27–S3. NCCLS, Wayne, PA. 2008
  11. Lackner M, Tscherner M, Schaller M et al. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment. Antimicrob Agents Ch. 2014;58: 3626- 35
  12. Castanheira M, Woosley LN, Diekema DJ et al. Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains. Antimicrob Agents Ch. 2010;54:2655-9
  13. Cheung Y-Y, Hui M. Effects of Echinocandins in combination with Nikkomycin Z against invasive Candida albicans bloodstream isolates and the fks mutants. Antimicrob Agents Ch. 2017;61: e00619-17
  14. Dudiuk C, Gamarra S, Leonardeli